Beijing-based Chinese private equity firm Hony Capital is to sell exit 650 million shares of Hong Kong-listed Chinese generic drugs maker CSPC Pharmaceutical Group Limited. forHK$6.30 apiece, in another exit from the company that will net Hony a total of HK$4.1 billion (US$528 million), according to CSPC’s official statement. The share sell-down equals to about 11% […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.